Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer.
Hamada A, Sasaki J, Saeki S, Iwamoto N, Inaba M, Ushijima S, Urata M, Kishi H, Fujii S, Semba H, Kashiwabara K, Tsubata Y, Kai Y, Isobe T, Kohrogi H, Saito H.
Hamada A, et al. Among authors: kashiwabara k.
Pharmacogenomics. 2012 Apr;13(5):615-24. doi: 10.2217/pgs.11.176.
Pharmacogenomics. 2012.
PMID: 22462752
Clinical Trial.